One-by-One test aims to match RA patients with their ideal drug

NCT ID NCT06016517

Summary

This study aims to find the best treatment order for individual patients with rheumatoid arthritis (RA) by testing four already-approved medications one after another. Eighteen adults with active RA who haven't responded fully to their first treatment will try each drug for 12 weeks. Researchers will closely track each person's pain, joint swelling, and overall quality of life to see which medication works best for them.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS, RHEUMATOID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tufts Medical Center

    Boston, Massachusetts, 02111, United States

Conditions

Explore the condition pages connected to this study.